Ep. 377: Julianna Carella, Treatibles

Julianna Carella returns and shares how Treatibles is handling FDA regulations: “It’s more important to keep the product on the shelf because now we have a situation where animals are relying on it, and last thing we want is for regulators to be confused about it and then pull the product.”

Ep. 376: Chuck Smith, Dixie Brands

Chuck Smith joins us and shares the potential of the States Act and its effect on the industry: “I think for the country to say, ‘Look, these are legitimate business people. They’re creating hundreds of thousands of jobs and creating a billion dollars worth of tax revenue. We need to treat them like any other […]

Ep. 375: The Paxhia, Poseidon Asset Management

The Paxhia on investment opportunity: “This is a fantastic period of time for investing in the space. Canada has not waited. They have war chests on their balance sheet of cash, not really much more they can build out in their market, so they’re eyeing other opportunities. The US is a huge opportunity set for […]

Ep. 374: Panaxia (Tour)

Arturo from Panaxia explains the processes and equipment that go into producing pharmaceutical cannabis: “Regular analytical systems allow you to see cannabinoids to the milligram level. This machine allows you to see to the nanogram levels, now that allows you to do two things. One of them is detect the levels of cannabinoids in the […]

Ep. 373: John Fowler, Supreme

John Fowler helps us to manage expectations and think positively on the future of the Legal Cannabis Market: “We had an election over the summer, and our new Premier decided that it was better to allow small or medium-sized businesses access to the market. What does that mean? We’re not going to have stores until […]

Ep. 372: Bruce Linton, Canopy Growth

Bruce Linton shares his thoughts on destigmatizing Cannabis from a medical perspective: “I would suggest that the doctors of yesteryear, who were living with the product in their presence might have a more valid perspective on its potential usefulness than the people who have been governing medicine in the absence of cannabis, who don’t want […]

Ep. 371: Michael Gorenstein, Cronos Group

Michael Gorenstein shares Cronos’ goals for expanding reach: “For us it’s about creating a global platform, and innovating products so that we can pilot these out, we can get the products in Canada, we can get them into consumers’ hands, and we’re on five continents now. We can immediately scale them globally.”

Ep. 370: Rafi Gamson, IQC

Rafi Gamson joins us and highlights the immense competition that’s growing in the Cannabis Production Market: “The investment is so big, I don’t believe so many farms will actually enter the market because it’s an open market. It’s not regulated. The market will regulate itself. The good ones will survive. The bad ones will actually […]

Episode #90 – AC Braddock, Eden Labs

In this episode we are joined by AC Braddock. Braddock is the CEO of Eden Labs, a company that designs and manufactures some of the highest quality CO2 extraction systems on the market. She tells us all about the different career paths she started on before she turned her entrepreneurial instincts to cannabis, and all […]

Episode #88 – Inyo Fine Cannabis Tour

We have another “Audio Tour” episode for you this week, and we’re taking you inside of Inyo Fine Cannabis in Las Vegas, NV. Inyo Fine Cannabis is one of the first dispensaries to open in Nevada, as the state rolls out their medical marijuana market. David Goldwater shows us the ins and outs of the […]